DiagnosTear Technologies Inc.
DiagnosTear Technologies Inc.
CSE Index:
Currency:
DiagnosTear is focused on the diagnosis of front-of-the-eye diseases at the point of care, by analyzing the composition of the tear fluid using its proprietary non invasive TeaRx™ technology and currently has two products for diagnosis of Dry Eye Disease and Red Eye causes.
DiagnosTear Technologies Inc. (DTR)
(%)
*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.
Company Info
Address
Manachem Plant 10
Rehorot 7670621
IsraelPhone
+972523408550Email
shimon@diagnostear.comWebsite
http://www.diagnostear.comListing date
Monday, December 9, 2024Transfer Agent
Endeavor Trust CorporationSEDAR Information
Filing Type
Any
Timeframe
1 week1 month3 month6 month1 yearAll Time
Company Info
Address
Manachem Plant 10
Rehorot 7670621
IsraelPhone
+972523408550Email
shimon@diagnostear.comWebsite
http://www.diagnostear.comListing date
Monday, December 9, 2024Transfer Agent
Endeavor Trust CorporationCapitalization
Issued & Outstanding:
58788335Reserved for Issuance:
7805670News Releases
05/02/2025
news Release February 5. 2025
Bulletins
05/12/2024
2024-1210 - New Listing - DiagnosTear Technologies Inc. (DTR)
Le 5 décembre/December 2024
The common shares of DiagnosTear Technologies Inc. have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
